248 related articles for article (PubMed ID: 21747416)
1. Performance of Lynch syndrome predictive models in a multi-center US referral population.
Khan O; Blanco A; Conrad P; Gulden C; Moss TZ; Olopade OI; Kupfer SS; Terdiman J
Am J Gastroenterol; 2011 Oct; 106(10):1822-7; quiz 1828. PubMed ID: 21747416
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
3. Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer.
Monzon JG; Cremin C; Armstrong L; Nuk J; Young S; Horsman DE; Garbutt K; Bajdik CD; Gill S
Int J Cancer; 2010 Feb; 126(4):930-9. PubMed ID: 19653273
[TBL] [Abstract][Full Text] [Related]
4. Validation of Prediction Models for Mismatch Repair Gene Mutations in Koreans.
Lee SY; Kim DW; Shin YK; Ihn MH; Lee SM; Oh HK; Ku JL; Jeong SY; Lee JB; Ahn S; Won S; Kang SB
Cancer Res Treat; 2016 Apr; 48(2):668-75. PubMed ID: 26044159
[TBL] [Abstract][Full Text] [Related]
5. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
[TBL] [Abstract][Full Text] [Related]
6. Identification of Lynch syndrome among patients with colorectal cancer.
Moreira L; Balaguer F; Lindor N; de la Chapelle A; Hampel H; Aaltonen LA; Hopper JL; Le Marchand L; Gallinger S; Newcomb PA; Haile R; Thibodeau SN; Gunawardena S; Jenkins MA; Buchanan DD; Potter JD; Baron JA; Ahnen DJ; Moreno V; Andreu M; Ponz de Leon M; Rustgi AK; Castells A;
JAMA; 2012 Oct; 308(15):1555-65. PubMed ID: 23073952
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer.
Kastrinos F; Ojha RP; Leenen C; Alvero C; Mercado RC; Balmaña J; Valenzuela I; Balaguer F; Green R; Lindor NM; Thibodeau SN; Newcomb P; Win AK; Jenkins M; Buchanan DD; Bertario L; Sala P; Hampel H; Syngal S; Steyerberg EW;
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26582061
[TBL] [Abstract][Full Text] [Related]
9. Comparison of predictive models, clinical criteria and molecular tumour screening for the identification of patients with Lynch syndrome in a population-based cohort of colorectal cancer patients.
Balmaña J; Balaguer F; Castellví-Bel S; Steyerberg EW; Andreu M; Llor X; Jover R; Castells A; Syngal S;
J Med Genet; 2008 Sep; 45(9):557-63. PubMed ID: 18603628
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.
Kastrinos F; Steyerberg EW; Balmaña J; Mercado R; Gallinger S; Haile R; Casey G; Hopper JL; LeMarchand L; Lindor NM; Newcomb PA; Thibodeau SN; Syngal S;
Gut; 2013 Feb; 62(2):272-9. PubMed ID: 22345660
[TBL] [Abstract][Full Text] [Related]
11. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer.
Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R
Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491
[TBL] [Abstract][Full Text] [Related]
12. Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases.
Mercado RC; Hampel H; Kastrinos F; Steyerberg E; Balmana J; Stoffel E; Cohn DE; Backes FJ; Hopper JL; Jenkins MA; Lindor NM; Casey G; Haile R; Madhavan S; de la Chapelle A; Syngal S;
Genet Med; 2012 Jul; 14(7):670-80. PubMed ID: 22402756
[TBL] [Abstract][Full Text] [Related]
13. Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries.
Monteiro Santos EM; Valentin MD; Carneiro F; de Oliveira LP; de Oliveira Ferreira F; Junior SA; Nakagawa WT; Gomy I; de Faria Ferraz VE; da Silva Junior WA; Carraro DM; Rossi BM
BMC Cancer; 2012 Feb; 12():64. PubMed ID: 22321913
[TBL] [Abstract][Full Text] [Related]
14. Criteria and prediction models for mismatch repair gene mutations: a review.
Win AK; Macinnis RJ; Dowty JG; Jenkins MA
J Med Genet; 2013 Dec; 50(12):785-93. PubMed ID: 23956446
[TBL] [Abstract][Full Text] [Related]
15. Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.
Fu L; Sheng JQ; Li XO; Jin P; Mu H; Han M; Huang JS; Sun ZQ; Li AQ; Wu ZT; Li SR
Cell Oncol (Dordr); 2013 Jun; 36(3):225-31. PubMed ID: 23640085
[TBL] [Abstract][Full Text] [Related]
16. Early-onset colorectal cancer is an easy and effective tool to identify retrospectively Lynch syndrome.
Perea J; Rodríguez Y; Rueda D; Marín JC; Díaz-Tasende J; Álvaro E; Alegre C; Osorio I; Colina F; Lomas M; Hidalgo M; Benítez J; Urioste M
Ann Surg Oncol; 2011 Nov; 18(12):3285-91. PubMed ID: 21590452
[TBL] [Abstract][Full Text] [Related]
17. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
Carethers JM; Stoffel EM
World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
[TBL] [Abstract][Full Text] [Related]
18. The identification of Lynch syndrome in Congolese colorectal cancer patients.
Poaty H; Aba Gandzion C; Soubeyran I; Gassaye D; Peko JF; Nkoua Bon JB; Gombé Mbalawa C
Bull Cancer; 2017 Oct; 104(10):831-839. PubMed ID: 28988047
[TBL] [Abstract][Full Text] [Related]
19. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study.
Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M
Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378
[TBL] [Abstract][Full Text] [Related]
20. BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.
Molinari F; Signoroni S; Lampis A; Bertan C; Perrone F; Sala P; Mondini P; Crippa S; Bertario L; Frattini M
Tumori; 2014; 100(3):315-20. PubMed ID: 25076244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
